PRKD1 (Protein Kinase D1)

2006-01-01   C Du , M Jaggi , W Zhang , KC Balaji 

Division of Urology, University of Massachusetts Memorial Medical Center, 55 Lake Avenue North, Worcester, MA 01605, USA

Identity

HGNC
LOCATION
14q12
LOCUSID
ALIAS
CHDED,PKC-MU,PKCM,PKD,PRKCM
FUSION GENES

DNA/RNA

Description

The gene spans over 351 kb and the transcript consists of 18 exons

Transcription

About 3.8 kb in length; Expressed in several organs with highest expression in kidney, heart and lungs.

Proteins

Atlas Image

Description

912 amino acids residues, 120 kDa on SDS-PAGE gel; contains an alanine and proline rich (AP), two cysteine-rich domains (CysI and CysII), acidic (AC), pleckstrin homology (PH) and kinase domain (KD). Several domain specific protein interactions and functions have been described (see figure below).

Localisation

In rested cells, the majority of PKD1 are in the cytoplasm. When activated by phorbol ester, PKD1 rapidly moves to plasma membrane and nucleus.

Function

Serine/threonine kinase; protein kinase C downstream effector; intracellular trafficking;
PKD1 has been shown to play a role in proliferation of keratinocytes in skin, B and T lymphocytes and mast cells signaling, possible role in development of central tolerance in thymus gland, proliferation of pancreatic cancer cells, cardiac myocyte contraction, endothelial cell proliferation, osteoblasts differentiation, and prostate cancer cells adhesion and invasion.

Homology

Homologues present in mouse and rat.

Implicated in

Entity name
Advanced prostate cancer
Disease
PKD1 phosphorylates E-cadherin in prostate cancer cell lines. E-cadherin phosphorylation is associated with altered cellular aggregation and motility in prostate cancer. Inhibition of PKD1 activity by the selective inhibitor Go6976 in LNCaP cells resulted in decreased cellular aggregation and over expression of PKD1 in C4-2 prostate cancer cells increased cellular aggregation and decreased cellular motility.

Entity name
Cardiac hypertrophy
Disease
Transcriptional regulation of gene expression is tightly coupled to histone deacetylases (HDAC) and histone acetyltransferase (HAT) that modify the access of transcription factors to DNA binding sites. PKD1 has been shown to participate in nuclear export of HDAC5. HDAC5 is phosphorylated by PKD1 in cardiac myocytes, which results in the binding of 14-3-3 protein to the phosphoserine motif on HDAC5, thus leading to nuclear export through a CRM1-dependent mechanism. This results in increased transcriptional activity of hypertrophy mediating genes in myocytes. Cardiac failure is usually preceded by cardiac hypertrophy that is mediated by altered gene expression involved in myocyte contraction, calcium handling and metabolism. PKD1 specific inhibitors may be of benefit in limiting cardiac hypertrophy.

Bibliography

Pubmed IDLast YearTitleAuthors

Other Information

Locus ID:

NCBI: 5587
MIM: 605435
HGNC: 9407
Ensembl: ENSG00000184304

Variants:

dbSNP: 5587
ClinVar: 5587
TCGA: ENSG00000184304
COSMIC: PRKD1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000184304ENST00000331968Q15139
ENSG00000184304ENST00000415220F8WBA3
ENSG00000184304ENST00000490795H0YHS9
ENSG00000184304ENST00000546371H0YHL5
ENSG00000184304ENST00000549503F8VZ98
ENSG00000184304ENST00000616995Q15139
ENSG00000184304ENST00000651571A0A494C196
ENSG00000184304ENST00000651616A0A494C0Q1

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45
50

Pathways

PathwaySourceExternal ID
Rap1 signaling pathwayKEGGhsa04015
Rap1 signaling pathwayKEGGko04015
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Sphingolipid metabolismREACTOMER-HSA-428157
Sphingolipid de novo biosynthesisREACTOMER-HSA-1660661
Aldosterone synthesis and secretionKEGGhsa04925
Aldosterone synthesis and secretionKEGGko04925

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA128394595PLCH1GenePathwayassociated
PA134875646PLCZ1GenePathwayassociated
PA134914471PLCH2GenePathwayassociated
PA33384PLCB1GenePathwayassociated
PA33385PLCB2GenePathwayassociated
PA33386PLCB3GenePathwayassociated
PA33387PLCB4GenePathwayassociated
PA33388PLCD1GenePathwayassociated
PA33389PLCD3GenePathwayassociated
PA33390PLCD4GenePathwayassociated
PA33391PLCE1GenePathwayassociated
PA33392PLCG1GenePathwayassociated
PA33393PLCG2GenePathwayassociated
PA33394PLCL1GenePathwayassociated
PA33395PLCL2GenePathwayassociated

References

Pubmed IDYearTitleCitations
193299942009Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot.116
150240532004Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.95
147432172004Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network.94
161666342005Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species.90
183321342008Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis.78
175919192007Regulation of secretory transport by protein kinase D-mediated phosphorylation of the ceramide transfer protein.77
157281882005A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D.75
188294542008Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.73
274799072016Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.73
119785392002Protein kinase D: an intracellular traffic regulator on the move.66

Citation

C Du ; M Jaggi ; W Zhang ; KC Balaji

PRKD1 (Protein Kinase D1)

Atlas Genet Cytogenet Oncol Haematol. 2006-01-01

Online version: http://atlasgeneticsoncology.org/gene/41860/prkd1